We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
Cap. Flow
+$280M
Cap. Flow %
7.43%
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$115M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$57.1M
4
LLY icon
Eli Lilly
LLY
+$51.1M
5
QRVO icon
Qorvo
QRVO
+$47.7M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$72.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$66.5M
3
AMZN icon
Amazon
AMZN
+$65.6M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$58.8M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$53.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.9%
2 Technology 32.83%
3 Communication Services 8.98%
4 Financials 3.92%
5 Consumer Discretionary 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXST icon
201
Nexstar Media Group
NXST
$5.99B
$1.67M 0.04%
+15,250
New +$1.49M
SGTX
202
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$1.56M 0.04%
+2,495
New +$1.13M
WW
203
DELISTED
WW International
WW
$1.48M 0.04%
+60,709
New +$1.58M
DASH icon
204
DoorDash
DASH
$88.2B
$1.43M 0.04%
+10,000
New +$1.6M
ACCD
205
DELISTED
Accolade Inc
ACCD
$1.22M 0.03%
28,077
+702
+3% +$31.2K
VERO
206
DELISTED
Venus Concept
VERO
$1.21M 0.03%
+4,242
New +$1.58M
BCRX icon
207
BioCryst Pharmaceuticals
BCRX
$2.29B
$1.16M 0.03%
155,844
-712,864
-82% -$3.67M
NBTX
208
Nanobiotix
NBTX
$2.01B
$1.16M 0.03%
+70,000
New +$1.21M
IOVA icon
209
Iovance Biotherapeutics
IOVA
$1.95B
$1M 0.03%
21,574
-177,110
-89% -$7.03M
COR icon
210
Cencora
COR
$59.6B
$881K 0.02%
9,016
-123,812
-93% -$12.4M
RTP.WS
211
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$687K 0.02%
+211,306
New +$572K
PACE.WS
212
DELISTED
TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary
PACE.WS
$671K 0.02%
+311,871
New +$739K
FUSN
213
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$621K 0.02%
52,827
-23,266
-31% -$292K
FRLN
214
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$474K 0.01%
1,729
-12,032
-87% -$3.02M
SVRA icon
215
Savara
SVRA
$1.11B
$431K 0.01%
374,904
-218,690
-37% -$264K
BDSX icon
216
Biodesix
BDSX
$236M
$231K 0.01%
+573
New +$178K
ABEO icon
217
Abeona Therapeutics
ABEO
$389M
– –
-43,256
Closed -$1.1M
ADI icon
218
Analog Devices
ADI
$185B
– –
-36,051
Closed -$4.21M
AMBA icon
219
Ambarella
AMBA
$3.61B
– –
-182,089
Closed -$9.5M
AMD icon
220
Advanced Micro Devices
AMD
$846B
– –
-193,514
Closed -$15.9M
AMED
221
DELISTED
Amedisys
AMED
– –
-59,504
Closed -$14.1M
AMN icon
222
AMN Healthcare
AMN
$1.29B
– –
-101,744
Closed -$5.95M
AMZN icon
223
Amazon
AMZN
$2.99T
– –
-416,700
Closed -$65.6M
ANNX icon
224
Annexon
ANNX
$873M
– –
-200,738
Closed -$6.07M
ARCT icon
225
Arcturus Therapeutics
ARCT
$177M
– –
-39,016
Closed -$1.67M
7 8
9
10 11

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.

  • Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
  • Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
  • Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
  • Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
  • Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
  • Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
  • Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.

Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.